Risk Factors for Mortality in Liver Transplant Recipients With ESKAPE Infection

Abstract Background Although infections caused by the pathogens Enterococcus faecium , Staphylococcus aureus , Klebsiella pneumoniae , Acinetobacter baumannii , Pseudomonas aeruginosa , and Enterobacter spp (ESKAPE) have recently been identified as serious emerging problems in solid organ transplant...

Full description

Saved in:
Bibliographic Details
Published inTransplantation proceedings Vol. 46; no. 10; pp. 3560 - 3563
Main Authors Song, S.H, Li, X.X, Wan, Q.Q, Ye, Q.F
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.12.2014
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract Background Although infections caused by the pathogens Enterococcus faecium , Staphylococcus aureus , Klebsiella pneumoniae , Acinetobacter baumannii , Pseudomonas aeruginosa , and Enterobacter spp (ESKAPE) have recently been identified as serious emerging problems in solid organ transplant, no information in liver transplant (LT) recipients is available. We sought to investigate the risk factors for associated mortality in LT recipients with ESKAPE infections. Methods A retrospective analysis of infection after LT was reviewed. Risk factors for mortality caused by ESKAPE infection were identified. Results Fifty-three episodes of infections caused by ESKAPE were documented in 51 LT recipients. The main sites of infection were the bloodstream (49.0%), the lungs (33.3%), and the intra-abdominal/biliary tract (17.6%). The risk factors for mortality independently associated with ESKAPE infection were female sex (odds ratio [OR] = 6.6, 95% confidence interval [CI] = 1.1–40.8, P  = .042), septic shock (OR = 30.1, 95% CI = 3.7–244.8, P  = .001), and lymphocyte counts <300/mm3 (OR = 20.2, 95% CI = 2.9–142.2, P  = .003). Conclusions To improve the results of LT, more effective therapeutic treatments are of paramount importance when female LT recipients with ESKAPE infection present with septic shock and decreased lymphocyte counts.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0041-1345
1873-2623
DOI:10.1016/j.transproceed.2014.08.049